OHIO —Lung cancer patients with moderate to severe depression are 2- to 3-times more likely to have inflammation levels that predict poor survival rates, according to results of a new Ohio State University study.
The results may help explain why a substantial portion of lung cancer patients fail to respond to new immunotherapy and targeted treatments that have led to significantly longer survival for many people with the disease.
Spectrum News spoke with Dr. Barbara Andersen, a professor of psychology at The Ohio State University. Anderson discussed research data suggesting the importance of measuring and treating depression in patients with lung cancer.
Watch the full interview above.